<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="10" family="SymbolMT" color="#000000"/>
<text top="41" left="55" width="132" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Journal of Autoimmune Diseases</i></text>
<text top="41" left="187" width="27" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2007, </text>
<text top="41" left="214" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>4</b></text>
<text top="41" left="219" width="7" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:3</text>
<text top="41" left="395" width="159" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.jautoimdis.com/content/4/1/3</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t6" reading_order_no="118" segment_no="16" tag_type="text">Page 4 of 12</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="119" segment_no="17" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="76" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="title"><i><b>Statistical analysis</b></i></text>
<text top="98" left="55" width="241" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">Results are expressed as mean ± SD. Data were analysed by</text>
<text top="110" left="55" width="5" height="9" font="font5" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">x</text>
<text top="110" left="60" width="6" height="6" font="font6" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">2 </text>
<text top="110" left="65" width="231" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">(two-by-two with Yate's correction), Fisher's exact test,</text>
<text top="122" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">Mann-Whitney U-test (MWU), Kruskal-Wallis test and</text>
<text top="134" left="55" width="241" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">Spearman's rank correlation (r), where applicable. The</text>
<text top="145" left="55" width="241" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">variables significant in the univariate analysis entered a</text>
<text top="157" left="55" width="241" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">binary logistic regression model. Two-sided p values less</text>
<text top="169" left="55" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">than 0.05 were considered statistically significant. Confi-</text>
<text top="181" left="55" width="241" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">dence intervals (95% CI) were determined using the for-</text>
<text top="192" left="55" width="106" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="4" tag_type="text">mula P = p ± 1.96 (pq/n)</text>
<text top="192" left="162" width="12" height="6" font="font6" id="p1_t20" reading_order_no="17" segment_no="4" tag_type="text">1/2 </text>
<text top="192" left="174" width="123" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="4" tag_type="text">where p is the frequency, q is</text>
<text top="204" left="55" width="241" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="4" tag_type="text">1-p and n is the number of individuals tested from each</text>
<text top="216" left="55" width="241" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="4" tag_type="text">group. The Documenta Geigy Scientific Table (Ciba-Geigy</text>
<text top="228" left="55" width="137" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="4" tag_type="text">Ltd, Basle, Switzerland, 1972 7</text>
<text top="227" left="192" width="8" height="6" font="font6" id="p1_t25" reading_order_no="22" segment_no="4" tag_type="text">th </text>
<text top="228" left="201" width="95" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="4" tag_type="text">edition) was used for</text>
<text top="239" left="55" width="220" height="9" font="font5" id="p1_t27" reading_order_no="24" segment_no="4" tag_type="text">95% CI when fewer than 41 individuals were tested.</text>
<text top="263" left="55" width="36" height="10" font="font7" id="p1_t28" reading_order_no="25" segment_no="7" tag_type="title"><b>Results</b></text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t29" reading_order_no="26" segment_no="8" tag_type="text">The relevant demographic, clinical, biochemical, serolog-</text>
<text top="286" left="55" width="241" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="8" tag_type="text">ical, and histological data required for the calculation of</text>
<text top="298" left="55" width="241" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="8" tag_type="text">the revised IAHG score in the study population are shown</text>
<text top="310" left="55" width="45" height="9" font="font5" id="p1_t32" reading_order_no="29" segment_no="8" tag_type="text">in Table <a href="">1</a>.</text>
<text top="334" left="55" width="166" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="9" tag_type="title"><i><b>Specificity and sensitivity of IAHG score</b></i></text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="10" tag_type="text">The overall specificity (correctly negative/correctly nega-</text>
<text top="357" left="55" width="241" height="9" font="font5" id="p1_t35" reading_order_no="32" segment_no="10" tag_type="text">tive + false positive) of the revised IAHG scoring system</text>
<text top="369" left="55" width="241" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="10" tag_type="text">for the diagnosis of AIH in the context of the presence of</text>
<text top="380" left="55" width="241" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="10" tag_type="text">another liver disease was 98.1% (95% CI: 96.8–99.4%)</text>
<text top="392" left="55" width="241" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="10" tag_type="text">(T<a href="">able 2)</a>. In more detail, the specificity of the revised</text>
<text top="404" left="55" width="241" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="10" tag_type="text">IAHG scoring system for each liver disease was: 99.1%</text>
<text top="416" left="55" width="241" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="10" tag_type="text">(95% CI: 97.3–100%) in HBV, 98.9% (95% CI: 97–</text>
<text top="427" left="55" width="241" height="9" font="font5" id="p1_t41" reading_order_no="38" segment_no="10" tag_type="text">100%) in HCV, 96.4% (95% CI: 91.5–100%) in NAFLD,</text>
<text top="439" left="55" width="241" height="9" font="font5" id="p1_t42" reading_order_no="39" segment_no="10" tag_type="text">96.1% (95% CI: 90.7–100%) in ACLD namely 98% (95%</text>
<text top="451" left="55" width="241" height="9" font="font5" id="p1_t43" reading_order_no="40" segment_no="10" tag_type="text">CI: 93–100%) in PBC and 92.3% (95% CI: 82.1–100%)</text>
<text top="463" left="55" width="241" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="10" tag_type="text">in PSC, 96.9% (95% CI: 90.9–100%) in patients with</text>
<text top="474" left="55" width="241" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="10" tag_type="text">liver disorders of undefined origin and 100% in patients</text>
<text top="486" left="55" width="241" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="10" tag_type="text">with ALD, HDV and miscellaneous hepatic disorders</text>
<text top="498" left="55" width="41" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="10" tag_type="text">(T<a href="">able 2).</a></text>
<text top="521" left="55" width="241" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="13" tag_type="text">Only 8 out of 423 patients had an AIH score between 10</text>
<text top="533" left="55" width="241" height="9" font="font5" id="p1_t49" reading_order_no="46" segment_no="13" tag_type="text">and 15 (probable AIH), while none of these patients had</text>
<text top="545" left="55" width="241" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="13" tag_type="text">a score above 15 (definite AIH). During a follow-up</text>
<text top="557" left="55" width="241" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="13" tag_type="text">period of 30–52 months, 7 patients did not develop other</text>
<text top="568" left="55" width="241" height="9" font="font5" id="p1_t52" reading_order_no="49" segment_no="13" tag_type="text">features supportive of AIH diagnosis, while they</text>
<text top="580" left="55" width="241" height="9" font="font5" id="p1_t53" reading_order_no="50" segment_no="13" tag_type="text">responded favourably to the treatment given according to</text>
<text top="592" left="55" width="241" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="13" tag_type="text">their original diagnosis. The eighth patient that was classi-</text>
<text top="604" left="55" width="241" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="13" tag_type="text">fied initially as liver disorder of undefined origin has been</text>
<text top="615" left="55" width="73" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="13" tag_type="text">lost in follow-up.</text>
<text top="639" left="55" width="241" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="14" tag_type="text">The sensitivity (correctly positive/correctly positive + false</text>
<text top="651" left="55" width="241" height="9" font="font5" id="p1_t58" reading_order_no="55" segment_no="14" tag_type="text">negative) of the revised IAHG scoring system for detecting</text>
<text top="662" left="55" width="241" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="14" tag_type="text">AIH in association with any kind of other liver disease (n</text>
<text top="674" left="55" width="241" height="9" font="font5" id="p1_t60" reading_order_no="57" segment_no="14" tag_type="text">= 24) was 66.7% (95% CI: 44.7–84.4 %) with 8 out of 24</text>
<text top="686" left="55" width="241" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="14" tag_type="text">patients (3 with AIH/PBC, 2 with AIH/PSC, 1 with AIH/</text>
<text top="698" left="55" width="241" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="14" tag_type="text">ALD, 1 with AIH/HBV and 1 with AIH/HCV) achieving</text>
<text top="709" left="55" width="241" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="14" tag_type="text">aggregate score &lt;10. The remaining 16 patients (4 with</text>
<text top="721" left="55" width="241" height="9" font="font5" id="p1_t64" reading_order_no="61" segment_no="14" tag_type="text">AIH/PBC, 1 with AIH/PSC, 1 with AIH/ALD, 4 with AIH/</text>
<text top="87" left="313" width="241" height="9" font="font5" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">NAFLD, 3 with AIH/HBV, 1 with AIH/HDV and 2 with</text>
<text top="98" left="313" width="241" height="9" font="font5" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">AIH/HCV) had an AIH score between 10 and 15. In more</text>
<text top="110" left="313" width="241" height="9" font="font5" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">detail, the sensitivity of the score for detecting AIH in</text>
<text top="122" left="313" width="241" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">patients with AIH/PBC or AIH/PSC overlap syndromes (n</text>
<text top="134" left="313" width="241" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="3" tag_type="text">= 10) was 50% (95% CI: 19–81%) with 5 out of 10</text>
<text top="145" left="313" width="241" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="3" tag_type="text">patients with AIH/overlap syndromes achieving score</text>
<text top="157" left="313" width="241" height="9" font="font5" id="p1_t71" reading_order_no="68" segment_no="3" tag_type="text">&lt;10. However, the score was more sensitive in the detec-</text>
<text top="169" left="313" width="241" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="3" tag_type="text">tion of the coincidence of AIH and other liver disease (n =</text>
<text top="181" left="313" width="241" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="3" tag_type="text">14): 78.6% (95% CI: 57.7–100%) with only 3 out of 14</text>
<text top="192" left="313" width="121" height="9" font="font5" id="p1_t74" reading_order_no="71" segment_no="3" tag_type="text">patients achieving score &lt;10.</text>
<text top="216" left="313" width="232" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="title"><i><b>Parameters that associated with increased AIH score in </b></i></text>
<text top="228" left="313" width="184" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="title"><i><b>patients with chronic liver diseases (n = 423)</b></i></text>
<text top="239" left="313" width="241" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="6" tag_type="text">In the univariate analysis, parameters that significantly</text>
<text top="251" left="313" width="241" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="6" tag_type="text">differed between patients with liver diseases achieving</text>
<text top="263" left="313" width="241" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="6" tag_type="text">AIH score between 10 and 15 (n = 8) and those having a</text>
<text top="275" left="313" width="241" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="6" tag_type="text">negative score (aggregate score less than 10; n = 415) were</text>
<text top="286" left="313" width="106" height="9" font="font5" id="p1_t81" reading_order_no="78" segment_no="6" tag_type="text">as follows: a) positive (</text>
<text top="284" left="420" width="5" height="12" font="font8" id="p1_t82" reading_order_no="79" segment_no="6" tag_type="text">≥</text>
<text top="286" left="425" width="129" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="6" tag_type="text">1) score in liver biopsy (p =</text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t84" reading_order_no="81" segment_no="6" tag_type="text">0.015) and b) total score from the biopsy (p &lt; 0.001)</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t85" reading_order_no="82" segment_no="6" tag_type="text"><a href="">(Table 3). After bin</a>ary logistic regression analysis we</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t86" reading_order_no="83" segment_no="6" tag_type="text">found that the total histological score obtained from liver</text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="6" tag_type="text">biopsy, was the only independent factor that significantly</text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="6" tag_type="text">associated (p = 0.003) with a probable AIH score in non-</text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="6" tag_type="text">AIH patients with chronic liver diseases. Finally, the aggre-</text>
<text top="369" left="313" width="241" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="6" tag_type="text">gate score was significantly higher in the group of patients</text>
<text top="380" left="313" width="241" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="6" tag_type="text">with probable score compared to those achieving a nega-</text>
<text top="392" left="313" width="241" height="9" font="font5" id="p1_t92" reading_order_no="89" segment_no="6" tag_type="text">tive AIH score (11.63 ± 1.19 vs 2.29 ± 4.07; p &lt; 0.001;</text>
<text top="404" left="313" width="37" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="6" tag_type="text"><a href="">Table 3).</a></text>
<text top="428" left="313" width="122" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="11" tag_type="title"><i><b>Comparisons between groups</b></i></text>
<text top="439" left="313" width="241" height="9" font="font5" id="p1_t95" reading_order_no="92" segment_no="12" tag_type="text">In total (n = 24), patients with AIH/overlap syndromes</text>
<text top="451" left="313" width="241" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="12" tag_type="text">and AIH with concurrent other liver diseases had signifi-</text>
<text top="463" left="313" width="165" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="12" tag_type="text">cantly more frequently a positive score (</text>
<text top="460" left="478" width="5" height="12" font="font8" id="p1_t98" reading_order_no="95" segment_no="12" tag_type="text">≥</text>
<text top="463" left="484" width="70" height="9" font="font5" id="p1_t99" reading_order_no="96" segment_no="12" tag_type="text">1) in liver biopsy</text>
<text top="474" left="313" width="241" height="9" font="font5" id="p1_t100" reading_order_no="97" segment_no="12" tag_type="text">(p &lt; 0.001), higher total histological score (p &lt; 0.001),</text>
<text top="486" left="313" width="241" height="9" font="font5" id="p1_t101" reading_order_no="98" segment_no="12" tag_type="text">higher frequency of a positive score for serum globulin or</text>
<text top="498" left="313" width="241" height="9" font="font5" id="p1_t102" reading_order_no="99" segment_no="12" tag_type="text">IgG increase (p = 0.035) and higher frequency of concur-</text>
<text top="510" left="313" width="241" height="9" font="font5" id="p1_t103" reading_order_no="100" segment_no="12" tag_type="text">rent autoimmune diseases (p = 0.001) compared to those</text>
<text top="521" left="313" width="241" height="9" font="font5" id="p1_t104" reading_order_no="101" segment_no="12" tag_type="text">with liver diseases other than AIH (n = 42<a href="">3; Table 4)</a>. In</text>
<text top="533" left="313" width="241" height="9" font="font5" id="p1_t105" reading_order_no="102" segment_no="12" tag_type="text">addition, patients with AIH/overlap syndromes and AIH</text>
<text top="545" left="313" width="241" height="9" font="font5" id="p1_t106" reading_order_no="103" segment_no="12" tag_type="text">with concurrent other liver diseases (n = 24) tended to</text>
<text top="557" left="313" width="241" height="9" font="font5" id="p1_t107" reading_order_no="104" segment_no="12" tag_type="text">have more frequently autoantibodies detection compared</text>
<text top="568" left="313" width="241" height="9" font="font5" id="p1_t108" reading_order_no="105" segment_no="12" tag_type="text">to those (n = 423) with liver diseases other than AIH (p =</text>
<text top="580" left="313" width="241" height="9" font="font5" id="p1_t109" reading_order_no="106" segment_no="12" tag_type="text">0.06; Ta<a href="">ble 4). Howe</a>ver, when the variables, which were</text>
<text top="592" left="313" width="241" height="9" font="font5" id="p1_t110" reading_order_no="107" segment_no="12" tag_type="text">significant in the univariate analysis, entered the binary</text>
<text top="604" left="313" width="241" height="9" font="font5" id="p1_t111" reading_order_no="108" segment_no="12" tag_type="text">logistic regression model, the total histological score (p &lt;</text>
<text top="615" left="313" width="241" height="9" font="font5" id="p1_t112" reading_order_no="109" segment_no="12" tag_type="text">0.001), the seropositivity for autoantibodies (p &lt; 0.05)</text>
<text top="627" left="313" width="241" height="9" font="font5" id="p1_t113" reading_order_no="110" segment_no="12" tag_type="text">and the presence of other autoimmune diseases (p &lt;</text>
<text top="639" left="313" width="241" height="9" font="font5" id="p1_t114" reading_order_no="111" segment_no="12" tag_type="text">0.001) were identified as independent predictors for the</text>
<text top="651" left="313" width="241" height="9" font="font5" id="p1_t115" reading_order_no="112" segment_no="12" tag_type="text">presence of AIH associated with any kind of other liver</text>
<text top="662" left="313" width="41" height="9" font="font5" id="p1_t116" reading_order_no="113" segment_no="12" tag_type="text">disorders.</text>
<text top="686" left="313" width="241" height="9" font="font5" id="p1_t117" reading_order_no="114" segment_no="15" tag_type="text">After comparisons of the parameters of IAHG score</text>
<text top="698" left="313" width="241" height="9" font="font5" id="p1_t118" reading_order_no="115" segment_no="15" tag_type="text">among the group of patients with chronic liver disorders</text>
<text top="709" left="313" width="241" height="9" font="font5" id="p1_t119" reading_order_no="116" segment_no="15" tag_type="text">other than AIH (n = 423), the group of patients with AIH/</text>
<text top="721" left="313" width="241" height="9" font="font5" id="p1_t120" reading_order_no="117" segment_no="15" tag_type="text">overlap syndromes (n = 10) and the group of patients</text>
</page>
</pdf2xml>
